Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation

Journal of Neuroscience - United States
doi 10.1523/jneurosci.0234-09.2009
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Society for Neuroscience

Related search

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2009English

Inflammation‐induced Mammalian Target of Rapamycin Signaling Is Essential for Retina Regeneration

GLIA
Molecular NeuroscienceNeurologyCellular
2019English

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases

Biomedical Journal
Medicine
2013English

Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy

PLoS ONE
Multidisciplinary
2012English

Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids

European Oncology and Haematology
OncologyHematology
2015English

Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists

Breast Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy